Brigitte Slangen

8PUBLICATIONS
91CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)GlycoconjugatesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 01, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren

|Nov 23, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.

Iris A S Stroot, Joost Bart, Harry Hollema

|Jan 20, 2023
First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants.

Malou E Gelderblom, Veerle Jaspers, Reinier P Akkermans

|Aug 25, 2021
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II.

Maaike H M Oonk, Brian Slomovitz, Peter J W Baldwin

|Jan 22, 2021
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study).

Lara Terra, Maartje J Hooning, Bernadette A M Heemskerk-Gerritsen

|Jan 10, 2018
Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.

Marline G Harmsen, Jurgen M J Piek, Johan Bulten

Pageof 2

Frequent Collaborators

4 joint publications

Joanne de Hullu

3 joint publications

Marc van Beurden

2 joint publications

Eleonora van Dorst

2 joint publications

Margreet G E M Ausems